Association of the British Pharmaceutical Industry (1984) Post-marketing Surveillance of Medicines and the ABPI Code of Practice. Unpublished circular issued by the ABPI, London
2.
JonesColin D GLangmanM J SLawsonDHVesseyM P (1984) British Medical Journal286, 1713
3.
CrombieI KBrownS VHamleyJ G (1984) Journal of Epidemiology and Community Health38, 226–231
4.
InmanW H W (1985) In: Risk: Man-made hazards to man. Ed. CooperM. Oxford University Press, Oxford
5.
PEM News (1983) No. 1, August. Drug Surveillance Unit, University of Southampton
6.
PottsMFeldblumP JChiI-CLiaoWde la HabaFuertes A (1982) British Journal of Family Planning7, 99
7.
RamcharanS (1974) The Walnut Creek Contraceptive Drug Study. A prospective Study of the side effects of oral contraceptives, vol 1. National Institutes of Health, Bethesda
8.
RosenbergLHennekensC HRosnerBBelangerCRothmanK JSpeizerF E (1980) American Journal of Epidemiology111, 59
9.
Royal College of General Practitioners (1974) Oral Contraceptives and Health. Pitman Medical, London
10.
VesseyMDollRPetoRJohnsonBWigginsP (1976) Journal of Biosocial Science8, 373
